Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined array key "thumbnail" in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 25
StackHealth / Personalized glioblastoma vaccine shows early promise in trials

Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma

discovermagazine - Discover how a personalized DNA vaccine trained patients’ immune systems to target their own tumors, with one participant remaining cancer-free nearly five years later.

AI Summary: A customized vaccine targeting each patient's tumor has demonstrated encouraging immune responses and signs of clinical benefit against aggressive glioblastoma. Researchers report enhanced T‑cell activity and preliminary survival signals, suggesting personalized neoantigen vaccines may help control this stubborn brain cancer and warrant larger, controlled trials to confirm impact.

#biotech #drugdevelopment #oncology #cancerresearch #clinicaltrials #genetics #neuroscience

New models and datasets speeding brain tumor research

Walid Kamoun: The Intriguing Interactions Between Brain Tumor Cells and Microbial Ecosystem

17 days / oncodaily

Living 'tumor on a chip' could give best ever insight into aggressive brain cancer

18 days / medicalxpress

Pediatric radiology leaders launch AI brain tumor dataset

18 days / beckershospitalreview / Ella Jeffries


Next-gen glioblastoma immunotherapies: CAR T, drugs, stem cells

New drug candidate that reprograms the immune system shows promise as a brain cancer treatment

18 days / medicalxpress

Mouth stem cells could help beat brain cancer defenses

18 days / medicalxpress

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target

18 days / science / William T. Maich, Muhammad Vaseem Shaikh, Anish Puri, Martin A. Rossotti, Shan Grewal, Aapti Khanna,


Personalized glioblastoma vaccine: early immune and survival signals

Personalized Brain Cancer Vaccine May Help Against Aggressive Glioblastoma

18 days / discovermagazine

Glioblastoma vaccine shows promise: 3 study notes

19 days / beckershospitalreview / Elizabeth Gregerson

Personalized vaccine shows promise against aggressive brain cancer

19 days / medicalxpress


All Other Stories

New study could improve testing and treatment for rare brain, spinal cord, and eye cancers

9 days / medicalxpress

Q&A: Using advanced imaging to improve brain cancer treatment

9 days / medicalxpress

Giuseppe Lombardi: Highlights From The NMN Symposium 2026 On Novel Brain Tumor Therapies

11 days / oncodaily

A multi-level attention CNN-transformer based framework for the detection of brain tumor using regional dual-score explainability

11 days / nature

Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study

11 days / medicalxpress

Walter Urba Joins UbiVac to Help Guide Clinical Development of Dark Matter Cancer Vaccine

12 days / oncodaily

Catherine Alix-Panabières: Excited to Share our Latest Publication on Liquid Biopsy and Immunopeptidomics

15 days / oncodaily

Aya El Helali: Isoform-Level Mapping of Glioblastoma Using Long-Read Single-Cell Sequencing

16 days / oncodaily

Maveropepimut-S, pembrolizumab and low dose cyclophosphamide in metastatic ovarian cancer: phase 1/2 PESCO trial

18 days / nature

Personalized mRNA vaccine targets osteosarcoma relapse in first human use

18 days / medicalxpress

Back to Top / Wednesday, May 13, 2026, 11:23 am / permalink 23702 / 19 stories in 18 days /


Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61


Related Stories


Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Rogaratinib shows activity in SDH‑deficient GIST phase 2 trial / 43 hrs

CRISPR CD33‑deleted allogeneic transplant shows early AML promise / 15 days

Single‑cycle pembrolizumab yields striking responses in dMMR colon cancer / 20 days

Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 46 hrs

Common asthma drug may overcome immunotherapy resistance in cancers / 11 days

Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 13 days

MYC overactivity enables DNA repair and chemotherapy resistance in tumours / 13 days

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Novo Nordisk, Food Safety, Neuroscience, Reproductive Health and look for the RSS link.


↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.